SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001609351-19-000008
Filing Date
2019-01-08
Accepted
2019-01-08 16:30:38
Documents
1
Period of Report
2019-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_154698301969473.html 4  
1 FORM 4 wf-form4_154698301969473.xml 4 6749
  Complete submission text file 0001609351-19-000008.txt   8137
Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address
Mehra Anand (Reporting) CIK: 0001590102 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36819 | Film No.: 19516282

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Issuer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)